AMAG Pharmaceuticals Overview

AMAG Pharmaceuticals Operating Income

Operating Income for AMAG.

Quarterly Operating Income

$36.99M

↓ 305.25% YoY

As of Sep 30, 2020

Annual Operating Income (TTM)

$-36006000.00

↓ 69.13% YoY

Trailing 12 months ending Sep 30, 2020

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin